nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—BDKRB2—asthma	0.724	1	CbGaD
Icatibant—BDKRB2—respiratory system—asthma	0.00666	0.125	CbGeAlD
Icatibant—BDKRB2—smooth muscle tissue—asthma	0.00536	0.101	CbGeAlD
Icatibant—BDKRB2—trachea—asthma	0.00492	0.0922	CbGeAlD
Icatibant—ANPEP—respiratory system—asthma	0.00415	0.0778	CbGeAlD
Icatibant—BDKRB2—adrenal gland—asthma	0.00403	0.0756	CbGeAlD
Icatibant—BDKRB2—lung—asthma	0.00353	0.0663	CbGeAlD
Icatibant—ANPEP—adrenal cortex—asthma	0.00348	0.0653	CbGeAlD
Icatibant—ANPEP—epithelium—asthma	0.00347	0.065	CbGeAlD
Icatibant—ANPEP—bronchus—asthma	0.00342	0.0641	CbGeAlD
Icatibant—ANPEP—smooth muscle tissue—asthma	0.00334	0.0627	CbGeAlD
Icatibant—ANPEP—cardiovascular system—asthma	0.00318	0.0596	CbGeAlD
Icatibant—ANPEP—trachea—asthma	0.00307	0.0575	CbGeAlD
Icatibant—ANPEP—adrenal gland—asthma	0.00251	0.0472	CbGeAlD
Icatibant—ANPEP—lung—asthma	0.0022	0.0413	CbGeAlD
Icatibant—Body temperature increased—Ketotifen—asthma	0.000658	0.00734	CcSEcCtD
Icatibant—Headache—Dyphylline—asthma	0.000657	0.00732	CcSEcCtD
Icatibant—Dizziness—Terbutaline—asthma	0.000647	0.00722	CcSEcCtD
Icatibant—Nervous system disorder—Theophylline—asthma	0.000647	0.00721	CcSEcCtD
Icatibant—Headache—Isoprenaline—asthma	0.000638	0.00711	CcSEcCtD
Icatibant—Body temperature increased—Zileuton—asthma	0.000637	0.00711	CcSEcCtD
Icatibant—Body temperature increased—Orciprenaline—asthma	0.000623	0.00695	CcSEcCtD
Icatibant—Nausea—Dyphylline—asthma	0.000622	0.00694	CcSEcCtD
Icatibant—Rash—Terbutaline—asthma	0.000617	0.00688	CcSEcCtD
Icatibant—Dermatitis—Terbutaline—asthma	0.000617	0.00688	CcSEcCtD
Icatibant—Headache—Terbutaline—asthma	0.000613	0.00684	CcSEcCtD
Icatibant—Body temperature increased—Nedocromil—asthma	0.00061	0.0068	CcSEcCtD
Icatibant—Nausea—Isoprenaline—asthma	0.000605	0.00674	CcSEcCtD
Icatibant—Hypersensitivity—Zileuton—asthma	0.000594	0.00662	CcSEcCtD
Icatibant—Hypersensitivity—Indacaterol—asthma	0.000585	0.00652	CcSEcCtD
Icatibant—Body temperature increased—Fluticasone furoate—asthma	0.000583	0.0065	CcSEcCtD
Icatibant—Nausea—Terbutaline—asthma	0.000582	0.00648	CcSEcCtD
Icatibant—Hypersensitivity—Orciprenaline—asthma	0.000581	0.00648	CcSEcCtD
Icatibant—Anaphylactic shock—Cromoglicic acid—asthma	0.000573	0.00639	CcSEcCtD
Icatibant—Hypersensitivity—Nedocromil—asthma	0.000569	0.00634	CcSEcCtD
Icatibant—Dizziness—Ketotifen—asthma	0.000551	0.00614	CcSEcCtD
Icatibant—Body temperature increased—Zafirlukast—asthma	0.000548	0.00611	CcSEcCtD
Icatibant—Hypersensitivity—Fluticasone furoate—asthma	0.000543	0.00606	CcSEcCtD
Icatibant—Dizziness—Zileuton—asthma	0.000533	0.00594	CcSEcCtD
Icatibant—Dizziness—Indacaterol—asthma	0.000525	0.00586	CcSEcCtD
Icatibant—Rash—Ketotifen—asthma	0.000525	0.00585	CcSEcCtD
Icatibant—Dermatitis—Ketotifen—asthma	0.000524	0.00585	CcSEcCtD
Icatibant—Anaphylactic shock—Ipratropium bromide—asthma	0.000524	0.00584	CcSEcCtD
Icatibant—Headache—Ketotifen—asthma	0.000522	0.00581	CcSEcCtD
Icatibant—Dizziness—Orciprenaline—asthma	0.000521	0.00581	CcSEcCtD
Icatibant—Body temperature increased—Theophylline—asthma	0.000521	0.00581	CcSEcCtD
Icatibant—Nervous system disorder—Ipratropium bromide—asthma	0.000514	0.00573	CcSEcCtD
Icatibant—Dizziness—Nedocromil—asthma	0.00051	0.00569	CcSEcCtD
Icatibant—Hypersensitivity—Zafirlukast—asthma	0.00051	0.00569	CcSEcCtD
Icatibant—Rash—Zileuton—asthma	0.000508	0.00567	CcSEcCtD
Icatibant—Dermatitis—Zileuton—asthma	0.000508	0.00566	CcSEcCtD
Icatibant—Dizziness—Pirbuterol—asthma	0.000507	0.00565	CcSEcCtD
Icatibant—Anaphylactic shock—Fluticasone Propionate—asthma	0.000507	0.00565	CcSEcCtD
Icatibant—Anaphylactic shock—Salmeterol—asthma	0.000506	0.00564	CcSEcCtD
Icatibant—Headache—Zileuton—asthma	0.000505	0.00563	CcSEcCtD
Icatibant—Rash—Indacaterol—asthma	0.000501	0.00558	CcSEcCtD
Icatibant—Dermatitis—Indacaterol—asthma	0.0005	0.00558	CcSEcCtD
Icatibant—Headache—Indacaterol—asthma	0.000498	0.00555	CcSEcCtD
Icatibant—Nervous system disorder—Fluticasone Propionate—asthma	0.000497	0.00554	CcSEcCtD
Icatibant—Nervous system disorder—Salmeterol—asthma	0.000496	0.00553	CcSEcCtD
Icatibant—Nausea—Ketotifen—asthma	0.000495	0.00551	CcSEcCtD
Icatibant—Headache—Orciprenaline—asthma	0.000494	0.00551	CcSEcCtD
Icatibant—Dizziness—Fluticasone furoate—asthma	0.000488	0.00544	CcSEcCtD
Icatibant—Rash—Nedocromil—asthma	0.000487	0.00543	CcSEcCtD
Icatibant—Dermatitis—Nedocromil—asthma	0.000486	0.00542	CcSEcCtD
Icatibant—Hypersensitivity—Theophylline—asthma	0.000486	0.00542	CcSEcCtD
Icatibant—Headache—Nedocromil—asthma	0.000484	0.00539	CcSEcCtD
Icatibant—Rash—Pirbuterol—asthma	0.000483	0.00539	CcSEcCtD
Icatibant—Dermatitis—Pirbuterol—asthma	0.000483	0.00538	CcSEcCtD
Icatibant—Headache—Pirbuterol—asthma	0.00048	0.00535	CcSEcCtD
Icatibant—Anaphylactic shock—Aminophylline—asthma	0.00048	0.00535	CcSEcCtD
Icatibant—Nausea—Zileuton—asthma	0.000479	0.00534	CcSEcCtD
Icatibant—Nausea—Indacaterol—asthma	0.000472	0.00526	CcSEcCtD
Icatibant—Nervous system disorder—Aminophylline—asthma	0.000471	0.00525	CcSEcCtD
Icatibant—Nausea—Orciprenaline—asthma	0.000468	0.00522	CcSEcCtD
Icatibant—Rash—Fluticasone furoate—asthma	0.000465	0.00518	CcSEcCtD
Icatibant—Dermatitis—Fluticasone furoate—asthma	0.000465	0.00518	CcSEcCtD
Icatibant—Headache—Fluticasone furoate—asthma	0.000462	0.00515	CcSEcCtD
Icatibant—Nausea—Nedocromil—asthma	0.000458	0.00511	CcSEcCtD
Icatibant—Dizziness—Zafirlukast—asthma	0.000458	0.00511	CcSEcCtD
Icatibant—Nausea—Pirbuterol—asthma	0.000455	0.00508	CcSEcCtD
Icatibant—Anaphylactic shock—Loratadine—asthma	0.000454	0.00506	CcSEcCtD
Icatibant—Body temperature increased—Cromoglicic acid—asthma	0.000453	0.00505	CcSEcCtD
Icatibant—Nervous system disorder—Loratadine—asthma	0.000445	0.00496	CcSEcCtD
Icatibant—Nervous system disorder—Tiotropium—asthma	0.000444	0.00495	CcSEcCtD
Icatibant—Nausea—Fluticasone furoate—asthma	0.000438	0.00488	CcSEcCtD
Icatibant—Rash—Zafirlukast—asthma	0.000437	0.00487	CcSEcCtD
Icatibant—Dermatitis—Zafirlukast—asthma	0.000436	0.00487	CcSEcCtD
Icatibant—Dizziness—Theophylline—asthma	0.000436	0.00486	CcSEcCtD
Icatibant—Dizziness—Beclomethasone—asthma	0.000436	0.00486	CcSEcCtD
Icatibant—Headache—Zafirlukast—asthma	0.000434	0.00484	CcSEcCtD
Icatibant—Hypersensitivity—Cromoglicic acid—asthma	0.000422	0.00471	CcSEcCtD
Icatibant—Dizziness—Ciclesonide—asthma	0.000417	0.00465	CcSEcCtD
Icatibant—Rash—Beclomethasone—asthma	0.000416	0.00463	CcSEcCtD
Icatibant—Rash—Theophylline—asthma	0.000416	0.00463	CcSEcCtD
Icatibant—Dermatitis—Theophylline—asthma	0.000415	0.00463	CcSEcCtD
Icatibant—Dermatitis—Beclomethasone—asthma	0.000415	0.00463	CcSEcCtD
Icatibant—Headache—Beclomethasone—asthma	0.000413	0.00461	CcSEcCtD
Icatibant—Headache—Theophylline—asthma	0.000413	0.00461	CcSEcCtD
Icatibant—Nausea—Zafirlukast—asthma	0.000411	0.00459	CcSEcCtD
Icatibant—Body temperature increased—Fluticasone Propionate—asthma	0.000401	0.00447	CcSEcCtD
Icatibant—Body temperature increased—Salmeterol—asthma	0.0004	0.00446	CcSEcCtD
Icatibant—Rash—Ciclesonide—asthma	0.000398	0.00444	CcSEcCtD
Icatibant—Dermatitis—Ciclesonide—asthma	0.000397	0.00443	CcSEcCtD
Icatibant—Headache—Ciclesonide—asthma	0.000395	0.00441	CcSEcCtD
Icatibant—Nausea—Beclomethasone—asthma	0.000392	0.00437	CcSEcCtD
Icatibant—Nausea—Theophylline—asthma	0.000392	0.00437	CcSEcCtD
Icatibant—Anaphylactic shock—Mometasone—asthma	0.000389	0.00434	CcSEcCtD
Icatibant—Hypersensitivity—Ipratropium bromide—asthma	0.000386	0.0043	CcSEcCtD
Icatibant—Body temperature increased—Aminophylline—asthma	0.00038	0.00423	CcSEcCtD
Icatibant—Dizziness—Cromoglicic acid—asthma	0.000379	0.00423	CcSEcCtD
Icatibant—Nausea—Ciclesonide—asthma	0.000375	0.00418	CcSEcCtD
Icatibant—Hypersensitivity—Fluticasone Propionate—asthma	0.000373	0.00416	CcSEcCtD
Icatibant—Hypersensitivity—Salmeterol—asthma	0.000373	0.00415	CcSEcCtD
Icatibant—Anaphylactic shock—Formoterol—asthma	0.000365	0.00407	CcSEcCtD
Icatibant—Anaphylactic shock—Arformoterol—asthma	0.000365	0.00407	CcSEcCtD
Icatibant—Rash—Cromoglicic acid—asthma	0.000361	0.00403	CcSEcCtD
Icatibant—Dermatitis—Cromoglicic acid—asthma	0.000361	0.00403	CcSEcCtD
Icatibant—Headache—Cromoglicic acid—asthma	0.000359	0.004	CcSEcCtD
Icatibant—Body temperature increased—Loratadine—asthma	0.000359	0.004	CcSEcCtD
Icatibant—Nervous system disorder—Formoterol—asthma	0.000358	0.004	CcSEcCtD
Icatibant—Nervous system disorder—Arformoterol—asthma	0.000358	0.004	CcSEcCtD
Icatibant—Anaphylactic shock—Montelukast—asthma	0.000358	0.00399	CcSEcCtD
Icatibant—Hypersensitivity—Aminophylline—asthma	0.000354	0.00394	CcSEcCtD
Icatibant—Nervous system disorder—Montelukast—asthma	0.000351	0.00391	CcSEcCtD
Icatibant—Dizziness—Ipratropium bromide—asthma	0.000346	0.00386	CcSEcCtD
Icatibant—Anaphylactic shock—Salbutamol—asthma	0.000345	0.00385	CcSEcCtD
Icatibant—Nausea—Cromoglicic acid—asthma	0.000341	0.0038	CcSEcCtD
Icatibant—Nervous system disorder—Salbutamol—asthma	0.000338	0.00377	CcSEcCtD
Icatibant—Dizziness—Fluticasone Propionate—asthma	0.000335	0.00374	CcSEcCtD
Icatibant—Dizziness—Salmeterol—asthma	0.000334	0.00373	CcSEcCtD
Icatibant—Anaphylactic shock—Budesonide—asthma	0.000334	0.00373	CcSEcCtD
Icatibant—Hypersensitivity—Tiotropium—asthma	0.000334	0.00372	CcSEcCtD
Icatibant—Body temperature increased—Flunisolide—asthma	0.000332	0.0037	CcSEcCtD
Icatibant—Rash—Ipratropium bromide—asthma	0.00033	0.00368	CcSEcCtD
Icatibant—Dermatitis—Ipratropium bromide—asthma	0.00033	0.00368	CcSEcCtD
Icatibant—Headache—Ipratropium bromide—asthma	0.000328	0.00366	CcSEcCtD
Icatibant—Nervous system disorder—Budesonide—asthma	0.000328	0.00365	CcSEcCtD
Icatibant—Rash—Fluticasone Propionate—asthma	0.00032	0.00356	CcSEcCtD
Icatibant—Dermatitis—Fluticasone Propionate—asthma	0.000319	0.00356	CcSEcCtD
Icatibant—Rash—Salmeterol—asthma	0.000319	0.00355	CcSEcCtD
Icatibant—Dermatitis—Salmeterol—asthma	0.000318	0.00355	CcSEcCtD
Icatibant—Dizziness—Aminophylline—asthma	0.000318	0.00354	CcSEcCtD
Icatibant—Headache—Fluticasone Propionate—asthma	0.000318	0.00354	CcSEcCtD
Icatibant—Headache—Salmeterol—asthma	0.000317	0.00353	CcSEcCtD
Icatibant—Nausea—Ipratropium bromide—asthma	0.000311	0.00347	CcSEcCtD
Icatibant—Hypersensitivity—Flunisolide—asthma	0.000309	0.00345	CcSEcCtD
Icatibant—Body temperature increased—Mometasone—asthma	0.000308	0.00343	CcSEcCtD
Icatibant—Rash—Aminophylline—asthma	0.000303	0.00338	CcSEcCtD
Icatibant—Dermatitis—Aminophylline—asthma	0.000302	0.00337	CcSEcCtD
Icatibant—Nausea—Fluticasone Propionate—asthma	0.000301	0.00336	CcSEcCtD
Icatibant—Headache—Aminophylline—asthma	0.000301	0.00335	CcSEcCtD
Icatibant—Nausea—Salmeterol—asthma	0.0003	0.00335	CcSEcCtD
Icatibant—Dizziness—Loratadine—asthma	0.0003	0.00334	CcSEcCtD
Icatibant—Dizziness—Tiotropium—asthma	0.000299	0.00334	CcSEcCtD
Icatibant—Body temperature increased—Formoterol—asthma	0.000289	0.00322	CcSEcCtD
Icatibant—Body temperature increased—Arformoterol—asthma	0.000289	0.00322	CcSEcCtD
Icatibant—Rash—Loratadine—asthma	0.000286	0.00319	CcSEcCtD
Icatibant—Dermatitis—Loratadine—asthma	0.000286	0.00319	CcSEcCtD
Icatibant—Rash—Tiotropium—asthma	0.000286	0.00318	CcSEcCtD
Icatibant—Dermatitis—Tiotropium—asthma	0.000285	0.00318	CcSEcCtD
Icatibant—Nausea—Aminophylline—asthma	0.000285	0.00318	CcSEcCtD
Icatibant—Headache—Loratadine—asthma	0.000284	0.00317	CcSEcCtD
Icatibant—Headache—Tiotropium—asthma	0.000284	0.00316	CcSEcCtD
Icatibant—Body temperature increased—Montelukast—asthma	0.000283	0.00315	CcSEcCtD
Icatibant—Dizziness—Flunisolide—asthma	0.000278	0.00309	CcSEcCtD
Icatibant—Body temperature increased—Salbutamol—asthma	0.000273	0.00304	CcSEcCtD
Icatibant—Nausea—Loratadine—asthma	0.000269	0.003	CcSEcCtD
Icatibant—Hypersensitivity—Formoterol—asthma	0.000269	0.003	CcSEcCtD
Icatibant—Hypersensitivity—Arformoterol—asthma	0.000269	0.003	CcSEcCtD
Icatibant—Nausea—Tiotropium—asthma	0.000269	0.003	CcSEcCtD
Icatibant—BDKRB2—Peptide ligand-binding receptors—EDN1—asthma	0.000266	0.00199	CbGpPWpGaD
Icatibant—Rash—Flunisolide—asthma	0.000265	0.00295	CcSEcCtD
Icatibant—Dermatitis—Flunisolide—asthma	0.000264	0.00295	CcSEcCtD
Icatibant—Body temperature increased—Budesonide—asthma	0.000264	0.00295	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—SLC30A8—asthma	0.000264	0.00198	CbGpPWpGaD
Icatibant—Hypersensitivity—Montelukast—asthma	0.000264	0.00294	CcSEcCtD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL5—asthma	0.000264	0.00198	CbGpPWpGaD
Icatibant—Headache—Flunisolide—asthma	0.000263	0.00293	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—EDNRB—asthma	0.000262	0.00196	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR4—asthma	0.00026	0.00195	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—NPS—asthma	0.000259	0.00194	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—asthma	0.000259	0.00194	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL10—asthma	0.000258	0.00194	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—C3AR1—asthma	0.000256	0.00192	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—asthma	0.000255	0.00191	CbGpPWpGaD
Icatibant—Hypersensitivity—Salbutamol—asthma	0.000254	0.00283	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—asthma	0.000254	0.00191	CbGpPWpGaD
Icatibant—Nausea—Flunisolide—asthma	0.000249	0.00278	CcSEcCtD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—FN1—asthma	0.000247	0.00186	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CYSLTR2—asthma	0.000247	0.00185	CbGpPWpGaD
Icatibant—Hypersensitivity—Budesonide—asthma	0.000246	0.00275	CcSEcCtD
Icatibant—Rash—Mometasone—asthma	0.000245	0.00274	CcSEcCtD
Icatibant—Dermatitis—Mometasone—asthma	0.000245	0.00273	CcSEcCtD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—AGTR1—asthma	0.000245	0.00184	CbGpPWpGaD
Icatibant—Headache—Mometasone—asthma	0.000244	0.00272	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—C5—asthma	0.000242	0.00182	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—TACR1—asthma	0.000242	0.00182	CbGpPWpGaD
Icatibant—Dizziness—Arformoterol—asthma	0.000242	0.00269	CcSEcCtD
Icatibant—Dizziness—Formoterol—asthma	0.000242	0.00269	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—PLA2G7—asthma	0.000242	0.00181	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—asthma	0.000241	0.00181	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—LTB4R—asthma	0.000238	0.00179	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PTGDR—asthma	0.000238	0.00179	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR5—asthma	0.000237	0.00178	CbGpPWpGaD
Icatibant—Dizziness—Montelukast—asthma	0.000237	0.00264	CcSEcCtD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—ADRB2—asthma	0.000233	0.00175	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—C3AR1—asthma	0.000233	0.00175	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—C3—asthma	0.000232	0.00174	CbGpPWpGaD
Icatibant—Nausea—Mometasone—asthma	0.000231	0.00258	CcSEcCtD
Icatibant—Rash—Formoterol—asthma	0.00023	0.00257	CcSEcCtD
Icatibant—Rash—Arformoterol—asthma	0.00023	0.00257	CcSEcCtD
Icatibant—Dermatitis—Formoterol—asthma	0.00023	0.00257	CcSEcCtD
Icatibant—Dermatitis—Arformoterol—asthma	0.00023	0.00257	CcSEcCtD
Icatibant—Headache—Formoterol—asthma	0.000229	0.00255	CcSEcCtD
Icatibant—Headache—Arformoterol—asthma	0.000229	0.00255	CcSEcCtD
Icatibant—Dizziness—Salbutamol—asthma	0.000228	0.00254	CcSEcCtD
Icatibant—Rash—Montelukast—asthma	0.000226	0.00252	CcSEcCtD
Icatibant—Dermatitis—Montelukast—asthma	0.000225	0.00251	CcSEcCtD
Icatibant—Headache—Montelukast—asthma	0.000224	0.0025	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CYSLTR2—asthma	0.000224	0.00168	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCL5—asthma	0.000222	0.00167	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR3—asthma	0.000221	0.00166	CbGpPWpGaD
Icatibant—Dizziness—Budesonide—asthma	0.000221	0.00246	CcSEcCtD
Icatibant—Rash—Salbutamol—asthma	0.000218	0.00243	CcSEcCtD
Icatibant—Dermatitis—Salbutamol—asthma	0.000217	0.00242	CcSEcCtD
Icatibant—Nausea—Formoterol—asthma	0.000217	0.00242	CcSEcCtD
Icatibant—Nausea—Arformoterol—asthma	0.000217	0.00242	CcSEcCtD
Icatibant—BDKRB2—Direct p53 effectors—SERPINE1—asthma	0.000216	0.00162	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—LTB4R—asthma	0.000216	0.00162	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PTGDR—asthma	0.000216	0.00162	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL22—asthma	0.000216	0.00162	CbGpPWpGaD
Icatibant—Headache—Salbutamol—asthma	0.000216	0.00241	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—NPY—asthma	0.000216	0.00162	CbGpPWpGaD
Icatibant—Nausea—Montelukast—asthma	0.000213	0.00237	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—asthma	0.000211	0.00159	CbGpPWpGaD
Icatibant—Rash—Budesonide—asthma	0.000211	0.00235	CcSEcCtD
Icatibant—Dermatitis—Budesonide—asthma	0.000211	0.00235	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—asthma	0.00021	0.00158	CbGpPWpGaD
Icatibant—Headache—Budesonide—asthma	0.000209	0.00233	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—CMA1—asthma	0.000209	0.00157	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—AGTR2—asthma	0.000208	0.00156	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—asthma	0.000205	0.00154	CbGpPWpGaD
Icatibant—Nausea—Salbutamol—asthma	0.000205	0.00229	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—HRH4—asthma	0.000202	0.00152	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—NPSR1—asthma	0.000202	0.00152	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PMCH—asthma	0.000202	0.00152	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PTGDR2—asthma	0.000202	0.00152	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR5—asthma	0.0002	0.0015	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—ADRB2—asthma	0.000199	0.0015	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—EDNRB—asthma	0.000199	0.0015	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—BCL2—asthma	0.000199	0.00149	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—RHOA—asthma	0.000199	0.00149	CbGpPWpGaD
Icatibant—Nausea—Budesonide—asthma	0.000199	0.00221	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—CSF2RB—asthma	0.000198	0.00149	CbGpPWpGaD
Icatibant—Anaphylactic shock—Prednisolone—asthma	0.000198	0.00221	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—NPS—asthma	0.000197	0.00148	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—TAC1—asthma	0.000197	0.00148	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—C3—asthma	0.000196	0.00147	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—TACR2—asthma	0.000194	0.00146	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR8—asthma	0.000194	0.00146	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCR3—asthma	0.000193	0.00145	CbGpPWpGaD
Icatibant—Anaphylactic shock—Hydrocortisone—asthma	0.000193	0.00216	CcSEcCtD
Icatibant—Nervous system disorder—Hydrocortisone—asthma	0.00019	0.00211	CcSEcCtD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR5—asthma	0.000186	0.0014	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—POMC—asthma	0.000186	0.00139	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—NPSR1—asthma	0.000184	0.00138	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PMCH—asthma	0.000184	0.00138	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PTGDR2—asthma	0.000184	0.00138	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HRH4—asthma	0.000184	0.00138	CbGpPWpGaD
Icatibant—Anaphylactic shock—Triamcinolone—asthma	0.000182	0.00203	CcSEcCtD
Icatibant—Anaphylactic shock—Methylprednisolone—asthma	0.000182	0.00202	CcSEcCtD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL2—asthma	0.000182	0.00136	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CSF2RB—asthma	0.00018	0.00135	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	0.000178	0.00134	CbGpPWpGaD
Icatibant—Nervous system disorder—Methylprednisolone—asthma	0.000178	0.00199	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	0.000177	0.00133	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—TACR2—asthma	0.000176	0.00132	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR8—asthma	0.000176	0.00132	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL17—asthma	0.000173	0.0013	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PDE4A—asthma	0.00017	0.00127	CbGpPWpGaD
Icatibant—Anaphylactic shock—Dexamethasone—asthma	0.000165	0.00184	CcSEcCtD
Icatibant—Anaphylactic shock—Betamethasone—asthma	0.000165	0.00184	CcSEcCtD
Icatibant—BDKRB2—Direct p53 effectors—PTEN—asthma	0.000165	0.00124	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—asthma	0.000164	0.00123	CbGpPWpGaD
Icatibant—Nervous system disorder—Betamethasone—asthma	0.000162	0.00181	CcSEcCtD
Icatibant—Nervous system disorder—Dexamethasone—asthma	0.000162	0.00181	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—KNG1—asthma	0.000161	0.00121	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—AGTR1—asthma	0.00016	0.0012	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	0.000159	0.0012	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CYSLTR1—asthma	0.000159	0.00119	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—POMC—asthma	0.000157	0.00118	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL10—asthma	0.000156	0.00117	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—C3—asthma	0.000156	0.00117	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PDE4A—asthma	0.000154	0.00116	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—UTS2—asthma	0.000153	0.00115	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—C5AR1—asthma	0.000153	0.00115	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—VIP—asthma	0.000153	0.00115	CbGpPWpGaD
Icatibant—Body temperature increased—Hydrocortisone—asthma	0.000153	0.0017	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—ADRB2—asthma	0.000152	0.00114	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR4—asthma	0.000147	0.0011	CbGpPWpGaD
Icatibant—Hypersensitivity—Prednisolone—asthma	0.000146	0.00163	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CYSLTR1—asthma	0.000144	0.00108	CbGpPWpGaD
Icatibant—Body temperature increased—Triamcinolone—asthma	0.000144	0.0016	CcSEcCtD
Icatibant—Anaphylactic shock—Prednisone—asthma	0.000144	0.0016	CcSEcCtD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL8—asthma	0.000144	0.00108	CbGpPWpGaD
Icatibant—Hypersensitivity—Hydrocortisone—asthma	0.000142	0.00159	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—IL2RB—asthma	0.000142	0.00106	CbGpPWpGaD
Icatibant—Nervous system disorder—Prednisone—asthma	0.000141	0.00157	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—PDE4D—asthma	0.00014	0.00105	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—C5AR1—asthma	0.000139	0.00105	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL11—asthma	0.000139	0.00105	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—UTS2—asthma	0.000139	0.00105	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—VIP—asthma	0.000139	0.00105	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—C3AR1—asthma	0.000137	0.00103	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FCER2—asthma	0.000137	0.00103	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—TACR1—asthma	0.000137	0.00103	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PDE4B—asthma	0.000137	0.00103	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—C5—asthma	0.000137	0.00103	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—ACE—asthma	0.000137	0.00103	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—EDN1—asthma	0.000136	0.00102	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL5—asthma	0.000135	0.00101	CbGpPWpGaD
Icatibant—Hypersensitivity—Triamcinolone—asthma	0.000134	0.0015	CcSEcCtD
Icatibant—BDKRB2—Direct p53 effectors—EGFR—asthma	0.000134	0.00101	CbGpPWpGaD
Icatibant—Hypersensitivity—Methylprednisolone—asthma	0.000134	0.00149	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CCR4—asthma	0.000134	0.001	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CYSLTR2—asthma	0.000132	0.000993	CbGpPWpGaD
Icatibant—Dizziness—Prednisolone—asthma	0.000131	0.00146	CcSEcCtD
Icatibant—Body temperature increased—Dexamethasone—asthma	0.000131	0.00146	CcSEcCtD
Icatibant—Body temperature increased—Betamethasone—asthma	0.000131	0.00146	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—IL2RB—asthma	0.000129	0.000965	CbGpPWpGaD
Icatibant—Dizziness—Hydrocortisone—asthma	0.000128	0.00143	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—LTB4R—asthma	0.000128	0.000959	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTGDR—asthma	0.000128	0.000959	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL22—asthma	0.000128	0.000959	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PDE4D—asthma	0.000127	0.000957	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—EGFR—asthma	0.000127	0.000957	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR3—asthma	0.000125	0.000939	CbGpPWpGaD
Icatibant—Rash—Prednisolone—asthma	0.000125	0.00139	CcSEcCtD
Icatibant—Dermatitis—Prednisolone—asthma	0.000125	0.00139	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	0.000124	0.000934	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PDE4B—asthma	0.000124	0.000932	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—C5—asthma	0.000124	0.000932	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—TACR1—asthma	0.000124	0.000932	CbGpPWpGaD
Icatibant—Headache—Prednisolone—asthma	0.000124	0.00138	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—NPY—asthma	0.000122	0.000915	CbGpPWpGaD
Icatibant—Rash—Hydrocortisone—asthma	0.000122	0.00136	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	0.000122	0.000914	CbGpPWpGaD
Icatibant—Dermatitis—Hydrocortisone—asthma	0.000122	0.00136	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—CCR5—asthma	0.000121	0.00091	CbGpPWpGaD
Icatibant—Headache—Hydrocortisone—asthma	0.000121	0.00135	CcSEcCtD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL8—asthma	0.000121	0.000909	CbGpPWpGaD
Icatibant—Dizziness—Triamcinolone—asthma	0.00012	0.00134	CcSEcCtD
Icatibant—Dizziness—Methylprednisolone—asthma	0.00012	0.00134	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—C3—asthma	0.000118	0.00089	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AGTR2—asthma	0.000118	0.000883	CbGpPWpGaD
Icatibant—Nausea—Prednisolone—asthma	0.000118	0.00131	CcSEcCtD
Icatibant—Nausea—Hydrocortisone—asthma	0.000115	0.00128	CcSEcCtD
Icatibant—Rash—Triamcinolone—asthma	0.000115	0.00128	CcSEcCtD
Icatibant—Dermatitis—Triamcinolone—asthma	0.000115	0.00128	CcSEcCtD
Icatibant—Rash—Methylprednisolone—asthma	0.000115	0.00128	CcSEcCtD
Icatibant—Dermatitis—Methylprednisolone—asthma	0.000114	0.00128	CcSEcCtD
Icatibant—Headache—Triamcinolone—asthma	0.000114	0.00127	CcSEcCtD
Icatibant—Headache—Methylprednisolone—asthma	0.000114	0.00127	CcSEcCtD
Icatibant—Body temperature increased—Prednisone—asthma	0.000114	0.00127	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CCR3—asthma	0.000114	0.000853	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—EDNRB—asthma	0.000113	0.000845	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—NPS—asthma	0.000111	0.000837	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—TAC1—asthma	0.000111	0.000837	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—NPY—asthma	0.000111	0.000831	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCR3—asthma	0.000109	0.000821	CbGpPWpGaD
Icatibant—Dizziness—Betamethasone—asthma	0.000109	0.00122	CcSEcCtD
Icatibant—Dizziness—Dexamethasone—asthma	0.000109	0.00122	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—PMCH—asthma	0.000109	0.000815	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HRH4—asthma	0.000109	0.000815	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTGDR2—asthma	0.000109	0.000815	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NPSR1—asthma	0.000109	0.000815	CbGpPWpGaD
Icatibant—Nausea—Triamcinolone—asthma	0.000108	0.00121	CcSEcCtD
Icatibant—Nausea—Methylprednisolone—asthma	0.000108	0.0012	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—AGTR2—asthma	0.000107	0.000802	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CSF2RB—asthma	0.000106	0.000798	CbGpPWpGaD
Icatibant—Hypersensitivity—Prednisone—asthma	0.000106	0.00118	CcSEcCtD
Icatibant—Rash—Betamethasone—asthma	0.000104	0.00116	CcSEcCtD
Icatibant—Rash—Dexamethasone—asthma	0.000104	0.00116	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CCR8—asthma	0.000104	0.000782	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TACR2—asthma	0.000104	0.000782	CbGpPWpGaD
Icatibant—Dermatitis—Dexamethasone—asthma	0.000104	0.00116	CcSEcCtD
Icatibant—Dermatitis—Betamethasone—asthma	0.000104	0.00116	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—IL5—asthma	0.000104	0.000778	CbGpPWpGaD
Icatibant—Headache—Betamethasone—asthma	0.000103	0.00115	CcSEcCtD
Icatibant—Headache—Dexamethasone—asthma	0.000103	0.00115	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—EDNRB—asthma	0.000102	0.000768	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL17—asthma	0.000102	0.000767	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—TAC1—asthma	0.000101	0.00076	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—NPS—asthma	0.000101	0.00076	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCR3—asthma	9.93e-05	0.000745	CbGpPWpGaD
Icatibant—Nausea—Betamethasone—asthma	9.81e-05	0.00109	CcSEcCtD
Icatibant—Nausea—Dexamethasone—asthma	9.81e-05	0.00109	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—ADCY2—asthma	9.67e-05	0.000726	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IL3—asthma	9.64e-05	0.000724	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	9.63e-05	0.000723	CbGpPWpGaD
Icatibant—Dizziness—Prednisone—asthma	9.51e-05	0.00106	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	9.5e-05	0.000713	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—POMC—asthma	9.48e-05	0.000712	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL5—asthma	9.41e-05	0.000707	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL2—asthma	9.27e-05	0.000696	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—KIF3A—asthma	9.1e-05	0.000683	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PDE4A—asthma	9.1e-05	0.000683	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—KNG1—asthma	9.1e-05	0.000683	CbGpPWpGaD
Icatibant—Rash—Prednisone—asthma	9.07e-05	0.00101	CcSEcCtD
Icatibant—Dermatitis—Prednisone—asthma	9.06e-05	0.00101	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—AGTR1—asthma	9.04e-05	0.000679	CbGpPWpGaD
Icatibant—Headache—Prednisone—asthma	9.01e-05	0.001	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL10—asthma	8.84e-05	0.000663	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ADCY2—asthma	8.79e-05	0.00066	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL3—asthma	8.75e-05	0.000657	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—ADRB2—asthma	8.58e-05	0.000644	CbGpPWpGaD
Icatibant—Nausea—Prednisone—asthma	8.54e-05	0.000952	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CYSLTR1—asthma	8.52e-05	0.00064	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—LEP—asthma	8.48e-05	0.000637	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—KNG1—asthma	8.26e-05	0.00062	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VIP—asthma	8.23e-05	0.000618	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CMA1—asthma	8.23e-05	0.000618	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—UTS2—asthma	8.23e-05	0.000618	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL11—asthma	8.23e-05	0.000618	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—C5AR1—asthma	8.23e-05	0.000618	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AGTR1—asthma	8.21e-05	0.000616	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—ITPR1—asthma	8.11e-05	0.000609	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL10—asthma	8.02e-05	0.000602	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR4—asthma	7.89e-05	0.000592	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ADRB2—asthma	7.79e-05	0.000585	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—STAT6—asthma	7.74e-05	0.000581	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—EDN1—asthma	7.67e-05	0.000576	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCL5—asthma	7.61e-05	0.000571	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL2RB—asthma	7.6e-05	0.00057	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PDE4D—asthma	7.53e-05	0.000565	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CSF2—asthma	7.49e-05	0.000563	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ITPR1—asthma	7.37e-05	0.000553	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PDE4B—asthma	7.34e-05	0.000551	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—C5—asthma	7.34e-05	0.000551	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TACR1—asthma	7.34e-05	0.000551	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL8—asthma	7.33e-05	0.00055	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	7.3e-05	0.000548	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—POMC—asthma	7.29e-05	0.000547	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CCL2—asthma	7.13e-05	0.000535	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EDN1—asthma	6.96e-05	0.000523	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL5—asthma	6.91e-05	0.000519	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PLA2G4A—asthma	6.88e-05	0.000517	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR5—asthma	6.85e-05	0.000514	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CSF2—asthma	6.8e-05	0.000511	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IL2RA—asthma	6.75e-05	0.000507	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR3—asthma	6.71e-05	0.000504	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—C3—asthma	6.7e-05	0.000503	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NPY—asthma	6.54e-05	0.000491	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PPP2CA—asthma	6.34e-05	0.000476	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AGTR2—asthma	6.31e-05	0.000474	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR5—asthma	6.22e-05	0.000467	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL2RA—asthma	6.13e-05	0.00046	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—C3—asthma	6.08e-05	0.000457	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EDNRB—asthma	6.04e-05	0.000454	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TAC1—asthma	5.98e-05	0.000449	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NPS—asthma	5.98e-05	0.000449	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCR3—asthma	5.86e-05	0.00044	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CYBA—asthma	5.68e-05	0.000426	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CXCL8—asthma	5.64e-05	0.000423	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL5—asthma	5.56e-05	0.000417	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PARP1—asthma	5.56e-05	0.000417	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—POMC—asthma	5.36e-05	0.000402	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ADCY2—asthma	5.19e-05	0.00039	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL3—asthma	5.17e-05	0.000388	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—KNG1—asthma	4.88e-05	0.000366	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—POMC—asthma	4.86e-05	0.000365	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AGTR1—asthma	4.85e-05	0.000364	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL2—asthma	4.76e-05	0.000357	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6R—asthma	4.74e-05	0.000356	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL10—asthma	4.74e-05	0.000356	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—RHOA—asthma	4.72e-05	0.000354	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NTRK1—asthma	4.65e-05	0.000349	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ADRB2—asthma	4.6e-05	0.000345	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ITPR1—asthma	4.35e-05	0.000327	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—RHOA—asthma	4.29e-05	0.000322	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CD86—asthma	4.14e-05	0.000311	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL8—asthma	4.14e-05	0.000311	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EDN1—asthma	4.11e-05	0.000309	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL5—asthma	4.08e-05	0.000306	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PLA2G4A—asthma	4.06e-05	0.000305	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CSF2—asthma	4.02e-05	0.000302	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IL2—asthma	3.96e-05	0.000297	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SMAD3—asthma	3.91e-05	0.000294	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL8—asthma	3.76e-05	0.000282	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PPP2CA—asthma	3.74e-05	0.000281	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR5—asthma	3.68e-05	0.000276	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL2RA—asthma	3.62e-05	0.000272	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL2—asthma	3.6e-05	0.00027	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—C3—asthma	3.59e-05	0.00027	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PDGFB—asthma	3.5e-05	0.000263	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LEP—asthma	3.34e-05	0.000251	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FN1—asthma	3.15e-05	0.000237	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—POMC—asthma	2.87e-05	0.000216	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL2—asthma	2.81e-05	0.000211	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL6R—asthma	2.8e-05	0.00021	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EGFR—asthma	2.75e-05	0.000206	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SERPINE1—asthma	2.62e-05	0.000197	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RHOA—asthma	2.53e-05	0.00019	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOS3—asthma	2.51e-05	0.000188	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL8—asthma	2.22e-05	0.000167	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL2—asthma	2.12e-05	0.000159	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6—asthma	2.11e-05	0.000159	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MMP9—asthma	2.01e-05	0.000151	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTEN—asthma	2e-05	0.00015	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VEGFA—asthma	1.81e-05	0.000136	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—STAT3—asthma	1.79e-05	0.000134	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TGFB1—asthma	1.66e-05	0.000124	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—EGFR—asthma	1.62e-05	0.000122	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL6—asthma	1.25e-05	9.37e-05	CbGpPWpGaD
